Background: There is a critical need for contemporary education to address peritoneal surface malignancies (PSM). This study delineates the development of an online PSM curriculum for surgical trainees, in conjunction with a national consortium. Methods: A needs assessment survey was administered to attending surgical oncologists and trainees within the consortium, with a focus on current educational practices and preferences for PSM training. The identified focus areas informed the formulation of specific learning objectives and content. Results: The survey was completed by of 86/171 (48.5%) attending surgical oncologists in the group and 70 surgical trainees (56 residents and 14 fellows) from 31 unique institutions. Attending surgical oncologists emphasized trainee familiarity with general PSM principles and peritoneal metastases from lower gastrointestinal and gastric cancers when compared to gynecologic cancers and uncommon primaries (p < 0.001). Attending expectations increased incrementally with the trainee level in the knowledge and patient care domains. Attendings and trainees identified didactics and textbooks as primary modes of learning, although trainees reported using mobile learning tools more frequently. Disease site-specific educational content aligned with learning objectives was uploaded to a previously piloted online learning management system. Clinical management pathways and rotation guides were integrated to enhance the clinical applicability and consistency. Conclusions: Designing a PSM curriculum tailored to the educational needs of both attendants and trainees is feasible by using established pedagogical methods. This study provides a framework for teaching about complex diseases with limited educational literature.

The authors have declared no competing interest.

This work was supported partially by the Teaching Innovation Project Grant awarded by Yale University Center for Teaching and Learning to VVB, FG, DS, and KKT.

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Data from this study may be made available upon reasonable request from qualified medical or scientific professionals, provided that the request aligns with the specified purpose and may involve de-identified individual participant data. Access to the requested data is granted after signing a data-access agreement.